Lets hope they have success - although important to note their drug is looking to address a major symptom of PWS, which is constant hunger.
Which of course would also drive a lot of other health issues related to weight gain (blood pressure, diabetes, joint mobilisation, etc). No doubt beneficial for the community, but looking to target a specific (allbeit major) symptom of PWS, not addressing the disease specifically or a suite of symptoms.
I also hope - if successful - this drug doesnt go down the same path as Ozempic and is abused by those without essential need !!
PHASE2 PRADER WILLI SYNDROME START !!!!, page-41
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.30 |
Change
1.030(8.39%) |
Mkt cap ! $1.699B | |||
| Open | High | Low | Value | Volume |
| $12.95 | $13.39 | $12.79 | $8.230M | 629.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 480 | $13.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.33 | 249 | 2 |
View Market Depth
| Last trade - 15.35pm 06/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |